Electromagnetic vaccination

Abstract Numerous reports indicate robust mitogenic responses in human lymphocytes to low-frequency electromagnetic fields. We hypothesize that these observations reflect a wider platform for immune capability than presently recognized, whereby weak electromagnetic signals play the role of antigens. This notion hinges on whether pathogenic bacteria can emit correspondingly detectable electromagnetic signals. We make this case, recalling pertinent experimental evidence by Pohl and others implicating signal emission during cell replication due to rapid electric charge redistribution. If correct, this hypothesis would also offer a new approach to the coupled problems of hospital-acquired infections and rapid adaptations to antibacterial agents, suggesting the possible treatment of patients at risk using an electromagnetic vaccination procedure. Under the reasonable assumption that signals arising from diverse bacterial varieties can be separately catalogued, prophylaxis would be achieved by prior exposure of patients to electromagnetic signatures from high-morbidity sources. Among its potential advantages such treatment would be non-invasive, inexpensive, rapidly deployed, and conceivably, less likely to lose effectiveness over time due to bacterial adaptation.